A Novel Formulation of Docetaxel-Containing Micelle Surface Modified with Metronidazole to Target Tumor Hypoxia

Background Introduction Cancer is one of the leading causes of death globally, and despite significant progress in treatment, the complexity of tumors, particularly tumor hypoxia, remains a major obstacle to successful therapy. Hypoxic regions are prevalent in solid tumors, where oxygen concentrations are significantly lower than in normal tissues ...